Biotech failure, 2002 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech failure, 2002

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who started this subject	6/10/2002 8:16:04 PM
From: Miljenko Zuanic	Read Replies (1) of 130

Message 17582424 Monday June 10, 2:00 pm Eastern Time Press Release SOURCE: Wyeth Wyeth Discontinues Clinical Program for Its Type-2 Diabetes Candidate MADISON, N.J., June 10 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE - News) announced today that it is discontinuing clinical development of PTP-112. The decision was based on unsatisfactory Phase II clinical efficacy, as well as the occurrence of dose-limiting side effects among several trial participants.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next